Is GLP-1 Medication Good for Menopause? HRT Combination Guide

Yes, GLP-1 Medications Are Highly Effective for Menopause

GLP-1 medications work exceptionally well for menopausal weight gain. A 2025 analysis of 2,542 women from the SURMOUNT trials found tirzepatide produced 20-26% weight loss regardless of reproductive stage: premenopausal, perimenopausal, or postmenopausal. This debunks the myth that these medications are less effective during menopause.​

Why Menopause Creates Weight Challenges

Falling estrogen levels during perimenopause and menopause trigger:

GLP-1 medications directly counter these mechanisms by improving insulin sensitivity, reducing appetite, and targeting visceral fat.

Combining with HRT: Enhanced Results

The combination is not just safe—it’s superior. A 2025 Mayo Clinic observational study presented at ENDO 2025 showed postmenopausal women on both tirzepatide and hormone therapy lost 17% body weight versus 14% with tirzepatide alone. Hormone therapy appears to reverse metabolic changes that hinder weight loss.​

Semaglutide research showed similar findings: Postmenopausal women using HRT with semaglutide achieved 16% weight loss at 12 months versus 12% without HRT.​

Critical Safety Consideration: Oral HRT Absorption

Major warning: GLP-1 medications slow gastric emptying, reducing absorption of oral progestogens used in HRT. This compromises endometrial protection, increasing cancer risk for women with a uterus.​

Solution: Switch to non-oral HRT—transdermal patches, gels, or vaginal progesterone. These routes bypass the digestive system and remain fully effective.​

Bone Health Warning

Rapid weight loss from GLP-1 medications may worsen osteoporosis risk in menopausal women already prone to bone density loss. Discuss bone health monitoring with your clinician.

Bottom Line

GLP-1 medications are highly effective for menopausal weight loss and work synergistically with HRT. For optimal safety and results:​

  1. https://www.nyp.org/advances/article/women-in-menopause-benefit-from-glp-1-weight-loss-medications-as-much-as-younger-women
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC12015656/
  3. https://lifelong-health.org/why-glp%E2%80%911-medication-hrt-is-a-powerful-combination-for-weight-loss-in-perimenopausal-women/
  4. https://www.endocrine.org/news-and-advocacy/news-room/endo-annual-meeting/endo-2025-press-releases/castaneda-press-release
  5. https://www.oprahdaily.com/life/health/a65476576/hormone-therapy-glp-1-menopause-weight-loss-study/
  6. https://pubmed.ncbi.nlm.nih.gov/38446869/
  7. https://www.eastcroydonmc.co.uk/2025/08/15/for-patients-taking-glp-1-medications-and-oral-contraception-or-hrt/
  8. https://apps.nhslothian.scot/refhelp/guidelines/sexualreprohealth/menopause/hrt-and-incretin-based-therapies-glp-1-gip-ras/
  9. https://www.femtechworld.co.uk/menopause/weight-loss-jabs-may-worsen-bone-health-in-menopausal-women/
  10. https://www.pcwhs.co.uk/_userfiles/pages/files/resources/glp1_contraception_hrt_article.pdf
  11. https://www.thecardiologyadvisor.com/news/hormone-therapy-plus-tirzepatide-enhances-postmenopausal-weight-loss/
  12. https://pubmed.ncbi.nlm.nih.gov/39970049/
  13. https://thepauselife.com/blogs/the-pause-blog/glp-1s-and-hormone-therapy-a-game-changing-duo-for-menopause-belly-fat
  14. https://clinicaltrials.gov/study/NCT07057310
  15. https://www.pccarx.com/Blog/managing-menopausal-weight-gain-the-role-estrogen-plays-with-glp-1-agonists
  16. https://clinicaltrials.gov/study/NCT07218445
  17. https://www.mayo.edu/research/clinical-trials/cls-20581168
  18. https://thebms.org.uk/wp-content/uploads/2025/05/23-BMS-TfC-Use-of-incretin-based-therapies-APRIL2025-E.pdf

‍